Grifols: European Parliament postpones debate on plasma regulation


Bankinter : The legal proposal was to be discussed at the end of June, but has been left off the official agenda due to a legislative bottleneck. The next dates could be 18 July, 29 August or September.

Assessment: Positive news but with limited impact. In Europe it is estimated that 62% of the plasma consumed comes from donations and more than 30% is imported, mainly from the United States where donors sell their plasma. There is a willingness to introduce regulation to avoid this dependency. The creation of a new market in Europe would increase supply but the sector would have to pay for this plasma in the face of a foreseeable reduction in free donations and would lead to a deterioration in margins for companies in the sector.

About the Author

The Corner
The Corner has a team of on-the-ground reporters in capital cities ranging from New York to Beijing. Their stories are edited by the teams at the Spanish magazine Consejeros (for members of companies’ boards of directors) and at the stock market news site Consenso Del Mercado (market consensus). They have worked in economics and communication for over 25 years.